Biotech · Private company · Lowell, MA, US
Versatope Therapeutics, Inc.
Track this companyFree. Adds Versatope Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards5
- Recombinant Outer Membrane Vesicles as a Novel Adjuvant for a Malaria VaccineFiscal year 2026 · $999.9KNIH RePORTER 5R44AI181242-03 · fetched Nov 12, 2026
- Recombinant Outer Membrane Vesicles as a Novel Adjuvant for a Malaria VaccineFiscal year 2025 · $1MNIH RePORTER 5R44AI181242-02 · fetched Nov 12, 2026
- Advanced Development of a Universal Influenza VaccineFiscal year 2025 · $955.2KNIH RePORTER 75N93019C00060-P00031-9999-1 · fetched Nov 12, 2026
- Recombinant Outer Membrane Vesicles as a Novel Adjuvant for a Malaria VaccineFiscal year 2024 · $999.8KNIH RePORTER 1R44AI181242-01 · fetched Nov 12, 2026
- Advanced Development of Universal Vaccines for Universal InfluenzaFiscal year 2024 · $3.6MNIH RePORTER 75N93019C00060-P00025-9999-1 · fetched Nov 12, 2026